Anthony Martinez, MD  |  HIV Specialist/Hepatologist

As medical director of hepatology at ECMC, Dr. Anthony Martinez cares for outpatients with liver disease, including viral hepatitis, alcoholism, and fatty liver disease. In collaboration with the division of infectious diseases, he also evaluates and treats patients with hepatitis C virus (HCV) and HIV co-infection.

Outside of his outpatient practice at ECMC, Dr. Anthony Martinez focuses on research to improve hepatitis C treatments in populations disproportionately affected by HCV but with limited access to health care (including many American veterans, ethnic minority groups, injection drug users, and patients with psychological disorders) as well as developing novel modalities to deliver care.

The goal of his research is to expand HCV treatment services to a wide-ranging group of patients, especially those without immediate access to care, in an effort to reduce global disease burden. This may include training primary care or other providers to treat HCV and using telemedicine and co-localization as a way to increase treatment uptake in areas such as rural primary care clinics and methadone clinics.

Dr. Anthony Martinez is also co-investigator on numerous clinical trials related to new therapeutic agents for hepatitis C and fatty liver disease, including a study funded by the Centers for Disease Control and Prevention (CDC) to evaluate the use of telemedicine to treat HCV in methadone maintenance clinics. In addition, he lectures nationally about hepatitis C with an emphasis on opiate dependence and special populations.